NCT04301362View on ClinicalTrials.gov

Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients

UnknownOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

July 19, 2019

Primary Completion Date

July 19, 2021

Study Completion Date

December 19, 2021

Conditions
CancerThromboembolismThrombosisBiomarkers
Interventions
DIAGNOSTIC_TEST

Thrombosis biomarkers

Blood samples shall be prepared according to the manufacturer's instructions and stored at -80°C until analysis. Thrombin generation will be measured using the commercial kit STG®-Tromboscreen kit (Stago). The D-dimers will be quantified using STA LIATEST® D-DI PLUS (Stago).

Trial Locations (1)

4434-502

RECRUITING

Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia

Sponsors
All Listed Sponsors
collaborator

LEO Pharma

INDUSTRY

collaborator

Diagnostica Stago

INDUSTRY

lead

Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.

OTHER_GOV

NCT04301362 - Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients | Biotech Hunter | Biotech Hunter